Table 1.
Total | Age 18 to 79 | Age above 80 | |
---|---|---|---|
N = 366 | N = 192 | N = 174 | |
Median age (Interquartile range) | 78.5 (62-88) | 63 (45-74) | 89 (84-93) |
Male sex | 134 (36.6%) | 89 (46.3%) | 45 (25.8%) |
Blood culture positivity | 90 (24.5%) | 45 (23.4%) | 45 (25.8%) |
Infection site | |||
Urinary tract | 178 (48.6%) | 99 (51.5%) | 79 (45.4%) |
Pulmonary | 91 (24.8%) | 30 (15.6%) | 61 (35.0%) |
Skin & soft tissue | 68 (18.5%) | 38 (19.7%) | 30 (17.2%) |
Intra-abdominal | 14 (3.8%) | 8 (4.1%) | 6 (3.4%) |
Upper respiratory | 7 (1.9%) | 7 (3.6%) | 0 |
Cardiovascular | 6 (1.6%) | 3 (1.5%) | 3 (1.7%) |
Bone & joint | 5 (1.3%) | 4 (2.0%) | 1 (0.5%) |
Central nervous system | 4 (1.0%) | 3 (1.5%) | 1 (0.5%) |
Others | 14 (3.8%) | 8 (4.1%) | 6 (3.4%) |
Detected bacteria | 93 (25.4%) | 47 (24.4%) | 46 (26.4%) |
Esherichia coli | 45 | 22 | 23 |
Streptococcus dysgalactiae subsp. equisimilis | 11 | 7 | 4 |
Staphylococcus aureus | 10 | 4 | 6 |
Klebsiella pneumoniae | 6 | 2 | 4 |
Enterococcus faecalis | 3 | 0 | 3 |
Morganella morganii | 3 | 2 | 1 |
Proteus mirabilis | 3 | 2 | 1 |
Streptococcus agalactiae | 3 | 2 | 1 |
Others | 9 | 6 | 3 |
Death | 12 (3.2%) | 3 (1.5%) | 9 (5.1%) |